Related Experiment Video
Updated: May 24, 2026
10:39
Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
Published on: April 16, 2019
Local inflammation in chronic upper airway disease
Lien Calus1, Thibaut Van Zele, Lara Derycke
1Department of otorhinolaryngology, Ghent University Hospital, Ghent, Belgium.
Current Pharmaceutical Design
|March 7, 2012
Summary
Chronic rhinosinusitis (CRS) involves nasal and sinus inflammation, with distinct subtypes. Research highlights pathophysiological differences and the role of Staphylococcus aureus enterotoxins in CRS with nasal polyps and asthma, emphasizing the need for biomarkers and targeted therapies.
Area of Science:
- Immunology
- Otorhinolaryngology
- Allergy
Background:
- Chronic rhinosinusitis (CRS) is a prevalent upper airway inflammatory condition affecting the nose and paranasal sinuses.
- CRS is clinically classified into two main phenotypes: CRS with nasal polyps (CRSwNP) and CRS without nasal polyps (CRSsNP).
- CRSwNP frequently co-exists with asthma, a lower airway inflammatory disease.
Purpose of the Study:
- To review and highlight the pathophysiological distinctions between CRS phenotypes.
- To explore the role of T-cell patterns and superantigens in CRS.
- To identify the need for novel biomarkers and therapeutic strategies for CRS.
Main Methods:
- Literature review focusing on pathophysiological mechanisms in CRS.
- Analysis of T-cell patterns and the impact of Staphylococcus aureus enterotoxins.
- Examination of co-morbidities, particularly asthma in relation to CRS.
Main Results:
- Significant pathophysiological differences exist between CRS phenotypes regarding tissue remodeling and T-cell profiles.
- Staphylococcus aureus enterotoxins are implicated in CRSwNP and asthma, both characterized by T helper 2-biased immune responses.
- Currently, no validated biomarkers exist for CRS diagnosis or treatment monitoring.
Conclusions:
- Further phenotyping of CRS is crucial for developing new biomarkers and innovative treatments.
- Identifying and predicting individual patient responses to therapy remains a significant challenge in CRS research.
- Understanding the role of superantigens may lead to more targeted therapeutic approaches for specific CRS subtypes.
Related Concept Videos
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:12Chronic Inflammation: Introduction
Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
01:23Chronic Pharyngitis
Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:28Asthma I: Introduction
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD: